Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering PEG-Intron Supply Constraints Resolved; Earnings Forecast Cloudy

Executive Summary

Schering-Plough is ending its supply management program for PEG-Intron (peginterferon alfa-2b) based on enhanced production capacity for the hepatitis C agent

You may also be interested in...



Generic Ribavirin Labels Will Carve Out Rebetol/PEG-Intron Indication

Three Rivers Pharmaceuticals is amending its ribavirin ANDA to remove references to an 800 mg dose appearing in Schering-Plough's Rebetol labeling

Generic Ribavirin Labels Will Carve Out Rebetol/PEG-Intron Indication

Three Rivers Pharmaceuticals is amending its ribavirin ANDA to remove references to an 800 mg dose appearing in Schering-Plough's Rebetol labeling

Pharmacia II? Schering’s Hassan Brings In Former Colleagues; Zahn Leaves

Schering-Plough CEO Fred Hassan is bringing in three more former Pharmacia employees under a restructuring plan intended to globalize operations and eliminate several levels of management

Related Content

UsernamePublicRestriction

Register

PS041408

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel